Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for Revelation Biosciences, INC..
Filing timeline
BuySaleJennifer Carver
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
Closed purchases
Market purchases
6
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jennifer Carver: trading record in brief
Jennifer Carver discloses dealings in 2 companies, chiefly La Jolla Pharmaceutical Co and Revelation Biosciences, Inc. We count 21 filings; the first trade dates from 15 October 2018 and the latest from 17 August 2026.
No open-market sale appears; the market trades are 6 purchases worth €27k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 15 share grants.
A typical purchase (the median) is worth €5,373.
The latest filing, published on 18 August 2026, reports a share grant in Revelation Biosciences, Inc. The last purchase on record was published on 9 January 2019, which is 2,845 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jennifer Carver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
32,011 shares0Common StockSEC:0001193125-26-355658:0
1,661 shares@ US$1.875.0% of flowCommon StockSEC:0001193125-26-039693:0
41,981 shares@ US$0.9061.3% of flowCommon StockSEC:0001193125-26-010625:0
15,625 shares@ US$1.2832.5% of flowCommon StockSEC:0001193125-25-260419:0
181 shares@ US$3.871.3% of flowCommon StockSEC:0000950170-25-020120:0
230 shares@ US$4.85Common StockSEC:0000920465-19-000045:0
230 shares@ US$5.30Common StockSEC:0000920465-19-000035:0
1,260 shares@ US$5.13Common StockSEC:0000920465-19-000030:0
213 shares@ US$5.74Common StockSEC:0000920465-19-000016:0
516 shares@ US$6.19Common StockSEC:0000920465-19-000010:0
Canonical exit: 9 Apr 2019 (T+90)
484 shares@ US$6.19Common StockSEC:0000920465-19-000010:1
Canonical exit: 9 Apr 2019 (T+90)
1,000 shares@ US$6.17Common StockSEC:0000920465-19-000010:2
Canonical exit: 9 Apr 2019 (T+90)
1,000 shares@ US$6.15Common StockSEC:0000920465-19-000010:3
Canonical exit: 9 Apr 2019 (T+90)
1,000 shares@ US$6.16Common StockSEC:0000920465-19-000010:4
Canonical exit: 9 Apr 2019 (T+90)
1,000 shares@ US$6.17Common StockSEC:0000920465-19-000010:5
Canonical exit: 9 Apr 2019 (T+90)
148 shares@ US$8.02Common StockSEC:0000920465-19-000001:0
108 shares@ US$10.88Common StockSEC:0000920465-18-000065:0
96 shares@ US$12.30Common StockSEC:0000920465-18-000060:0
94 shares@ US$12.67Common StockSEC:0000920465-18-000056:0
85 shares@ US$13.86Common StockSEC:0000920465-18-000053:0
85 shares@ US$13.81Common StockSEC:0000920465-18-000039:0
21 of 21 declarations
